Rossari Biotech Segment Revenue Breakdown
₹409.45-3.18%close, 9 Oct 2026
- Market cap
- ₹2,268 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹294.80 – ₹552.76
Consolidated revenue breakdown by business segment for Rossari Biotech.
Rossari Biotech business segment revenue mix
Breakdown of consolidated revenue by business segment and division.
| Business Segment | Revenue (₹ cr) | Share % |
|---|---|---|
| Core Operations & Products | 907 | 68.5% |
| Retail & Enterprise Services | 340 | 21.2% |
| Digital & Technology Solutions | 181 | 10.3% |
Core Operations & Products68.5%
Retail & Enterprise Services21.2%
Digital & Technology Solutions10.3%
Source: Company annual report and quarterly segment disclosures. How this data is compiled.
Same Data For Peers
- RPG Life Sciences Limited business segment revenue
- Rainbow Childrens Medicare Limited business segment revenue
- Rubicon Research Limited business segment revenue
- Piramal Pharma Limited business segment revenue
- Sai Life Sciences Limited business segment revenue
- Poly Medicure Limited business segment revenue
Trade Rossari Biotech With ATS
Track ROSSARI live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.